After years of slowly building hype about its essential micronutrient function in the human body, ergothioneine may finally be ready for its moment – with just a little more research.
Boston-based biotech firm Conagen says it has come up with a novel and proprietary process for the scalable production of a non-GMO version of 2’-fucosyllactose (2’FL), a human milk oligosaccharide (HMO) found in human breastmilk that is becoming a sought-after...